New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
08:15 EDTNSRGY, AGN, VRXValeant says 'very confident' in meeting expectations for Q2, FY14
Valeant (VRX) says it will adjust its guidance on its Q2 earnings call to reflect the divestiture to Nestle (NSRGY) and its outlook for the rest of the year. Valeant says 13 of its top 15 products are growing overall and 9 of its top 15 products are growing by volume, refuting allegations made by Allergan (AGN). Comments from Valeant's "webcast to correct recent misrepresentations" related to its bid for Allergan.
News For VRX;AGN;NSRGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
17:34 EDTAGNActavis registration statement for Allergan acquisition declared effective
Subscribe for More Information
January 22, 2015
05:57 EDTVRXActavis, Valeant raise prospects of more healthcare deals, Financial Times says
Subscribe for More Information
January 21, 2015
12:30 EDTAGN, VRXGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information
January 20, 2015
06:51 EDTNSRGYNestle to invest about $140M in Egypt over next few years, Reuters says
Subscribe for More Information
January 16, 2015
10:01 EDTNSRGYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:32 EDTNSRGYNestle downgraded to Neutral from Buy at Natixis
Subscribe for More Information
05:32 EDTNSRGYNestle downgraded to Underperform from Neutral at Exane BNP Paribas

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use